TY - JOUR
T1 - “Official View” on Glucocorticoids in Rheumatoid Arthritis
T2 - A Systematic Review of International Guidelines and Consensus Statements
AU - Palmowski, Yannick
AU - Buttgereit, Thomas
AU - Dejaco, Christian
AU - Bijlsma, Johannes W.
AU - Matteson, Eric L.
AU - Voshaar, Marieke
AU - Boers, Maarten
AU - Buttgereit, Frank
N1 - Publisher Copyright:
© 2016, American College of Rheumatology
PY - 2017/8
Y1 - 2017/8
N2 - Objective: To describe the perception of the current role of systemic glucocorticoids in the management of rheumatoid arthritis (RA) by examining their importance and the current level of evidence in recent guidelines, and to identify open questions to be addressed in future guidelines and research projects. Methods: We conducted a systematic literature review using the databases Ovid Embase, PubMed Medline, and Cochrane Library for guidelines on the pharmacologic treatment of RA. Retrieved articles were evaluated regarding their quality using the Appraisal of Guidelines for Research and Evaluation II tool and scrutinized for all relevant information concerning the use of glucocorticoids. Results: All guidelines agree that glucocorticoids, especially if given at low doses and for a short duration, are an appropriate option in the treatment of RA. However, many recommendations remain vague, as reliable and detailed evidence is scarce. Important aspects of glucocorticoid therapy are partially or completely neglected, and the existing nomenclature is not used uniformly. Quality evaluation revealed flaws in many articles, concerning not only glucocorticoid-specific recommendations but also guideline quality in general. Conclusion: Current recommendations for use of glucocorticoids in the management of RA are suboptimal. More rigorous evaluation of doses, timing, and duration of their use is needed. Existing nomenclature on glucocorticoid therapy should be used uniformly.
AB - Objective: To describe the perception of the current role of systemic glucocorticoids in the management of rheumatoid arthritis (RA) by examining their importance and the current level of evidence in recent guidelines, and to identify open questions to be addressed in future guidelines and research projects. Methods: We conducted a systematic literature review using the databases Ovid Embase, PubMed Medline, and Cochrane Library for guidelines on the pharmacologic treatment of RA. Retrieved articles were evaluated regarding their quality using the Appraisal of Guidelines for Research and Evaluation II tool and scrutinized for all relevant information concerning the use of glucocorticoids. Results: All guidelines agree that glucocorticoids, especially if given at low doses and for a short duration, are an appropriate option in the treatment of RA. However, many recommendations remain vague, as reliable and detailed evidence is scarce. Important aspects of glucocorticoid therapy are partially or completely neglected, and the existing nomenclature is not used uniformly. Quality evaluation revealed flaws in many articles, concerning not only glucocorticoid-specific recommendations but also guideline quality in general. Conclusion: Current recommendations for use of glucocorticoids in the management of RA are suboptimal. More rigorous evaluation of doses, timing, and duration of their use is needed. Existing nomenclature on glucocorticoid therapy should be used uniformly.
UR - http://www.scopus.com/inward/record.url?scp=85023177893&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85023177893&partnerID=8YFLogxK
U2 - 10.1002/acr.23185
DO - 10.1002/acr.23185
M3 - Article
C2 - 28029750
AN - SCOPUS:85023177893
SN - 2151-464X
VL - 69
SP - 1134
EP - 1141
JO - Arthritis Care and Research
JF - Arthritis Care and Research
IS - 8
ER -